First-in-class, first-in-human phase I trial of KPT-330, a selective inhibitor of nuclear export (SINE) in patients (pts) with advanced solid tumors.

被引：0

作者：

Razak, Albiruni R. A.

Soerensen, Morten Mau

Mahipal, Amit

Shacham, Sharon

Yau, Cindy Y. F.

Lassen, Ulrik Niels

McCauley, Dilara

Cooksey, Jennifer

Tan, David Shao Peng

Saint-Martin, Jean-Richard

Landesman, Yossi

Pond, Gregory

Oza, Amit M.

Kauffman, Michael

Siu, Lillian L.

Mirza, Mansoor Raza

机构：

[1] Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Rigshosp, Dept Oncol, DK-2100 Copenhagen, Denmark

[3] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[4] Karyopharm Therapeut, Newton, MA USA

[5] Ozmosis Res Inc, Toronto, ON, Canada

[6] Rigshosp, DK-2100 Copenhagen, Denmark

[7] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2505

引用

页数：1